Breaking News, Financial News

Financial Report: Catalent

Medication Delivery segment drives growth in the quarter

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Catalent 2Q Revenues: $455.8 million (+3%) 2Q Earnings: $46.5 million (loss of $19.5 million 2Q13) YTD Revenues: $874.1 million (+2%) YTD Earnings: $27.0 million (loss of $17.7 million YTD13) Comments: Growth in the quarter was driven by the Medication Delivery Solutions segment and the modified release technologies business within the Oral Technologies segment, as well as increased demand for analytical services within the Development and Clinical Services. Oral Technologies revenue was $2...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters